510k
A premarket submission to the U.S. Food and Drug Administration demonstrating that a medical device is substantially equivalent to one already legally marketed. Clearance lets manufacturers sell moderate-risk devices without a full premarket approval study.
What is a 510k?
A 510k is a premarket submission made to the U.S. Food and Drug Administration to show that a new medical device is substantially equivalent to a legally marketed device, known as a predicate, that does not require premarket approval. The name comes from the section of the Federal Food, Drug, and Cosmetic Act that established the requirement.
Through a successful 510k, the manufacturer demonstrates that the new device has the same intended use and similar technological characteristics as the predicate, or that any differences do not raise new questions of safety and effectiveness. The FDA then issues a clearance, which is distinct from an approval, allowing the device to be marketed.
Why does the 510k pathway matter?
The 510k route is the most common way moderate-risk devices reach the market in the United States, because it avoids the time and expense of the full premarket approval process and its dedicated clinical studies. This makes it central to how surgical instruments, imaging accessories, and many implantables and tools used in procedural settings become available.
For facilities that purchase and use devices, understanding whether equipment was cleared through a 510k versus approved through a more rigorous pathway informs expectations about the evidence behind it. The clearance status can also matter for procurement, liability, and the regulatory documentation an organization keeps on its equipment.
- what is a 510k
- 510k fda clearance
- 510(k) premarket notification
- 510k submission meaning
- fda 510k substantial equivalence
- 510k vs pma